A detailed history of Cantor Fitzgerald, L. P. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 10,000 shares of BMEA stock, worth $62,800. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$62,800
Previous $45,000 124.44%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.14 - $15.3 $45,540 - $168,300
-11,000 Reduced 52.38%
10,000 $45,000
Q1 2024

May 15, 2024

BUY
$13.92 - $19.5 $292,320 - $409,500
21,000 New
21,000 $313,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $184M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Cantor Fitzgerald, L. P. Portfolio

Follow Cantor Fitzgerald, L. P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

News

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.